PRIVIGEN

This brand name is authorized in United States. It is also authorized in Austria, Canada, Croatia, Cyprus, Ecuador, Estonia, Finland, France, Hong Kong SAR China, Ireland, Israel, Italy, Japan, Lithuania, Netherlands, New Zealand, Poland, Romania, Singapore, Spain, Tunisia, Turkey, UK.

Active ingredients

The drug PRIVIGEN contains one active pharmaceutical ingredient (API):

1	Immunoglobulins, normal human, IV UNII RX2MM64U68 - HUMAN IMMUNOGLOBULINS
	Human normal immunoglobulin contains mainly immunoglobulin G (IgG) with a broad spectrum of antibodies against infectious agents. The mechanism of action in indications other than replacement therapy is not fully elucidated, but includes immunomodulatory effects.
	Read more about Immunoglobulins, normal human, IV

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
J06BA02	Immunoglobulins, normal human, for intravascular adm.	J Antiinfectives for systemic use → J06 Immune sera and immunoglobulins → J06B Immunoglobulins → J06BA Immunoglobulins, normal human
Discover more medicines within J06BA02

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
CA	Health Products and Food Branch	02304619
EC	Agencia Nacional de Regulación, Control y Vigilancia Sanitaria	103-MBE-0617
EE	Ravimiamet	1364228, 1364239, 1364240, 1462418, 1462429, 1462430, 1668326
ES	Centro de información online de medicamentos de la AEMPS	08446001, 08446002, 08446003, 08446004, 108446007
FI	Lääkealan turvallisuus- ja kehittämiskeskus	034401, 126684, 126695, 126707, 544385
FR	Base de données publique des médicaments	62946452
GB	Medicines & Healthcare Products Regulatory Agency	151462, 151465, 151469, 155458
HK	Department of Health Drug Office	62854, 62855, 62856, 63836
IL	מִשְׂרַד הַבְּרִיאוּת	7137, 7138
IT	Agenzia del Farmaco	039712017, 039712029, 039712031, 039712043, 039712056, 039712068, 039712070
JP	医薬品医療機器総合機構	6343427A7020, 6343427A7038, 6343427A8026, 6343427A8034, 6343427A9022, 6343427A9030, 6343427H1020
LT	Valstybinė vaistų kontrolės tarnyba	1032834, 1032835, 1032836, 1056687, 1056688, 1056689, 1071804
NL	Z-Index G-Standaard, PRK	135658, 80047, 80055, 80063, 80071
NZ	Medicines and Medical Devices Safety Authority	14649
PL	Rejestru Produktów Leczniczych	100214904
RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	W53030001, W53030002, W53030003, W53030004, W53030005
SG	Health Sciences Authority	15574P
TN	Direction de la Pharmacie et du Médicament	13813021H, 13813022H, 13813023H
TR	İlaç ve Tıbbi Cihaz Kurumu	8681624980149, 8681624980156, 8681624980163
US	FDA, National Drug Code	44206-436, 44206-437, 44206-438, 44206-439